Lexaria Bioscience -CW25LEXXWPreferred / convertible
13F holders, Q1 2024 (March 31)3holders
$1.50avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Lexaria Bioscience -CW25 (LEXXW) in their 13F filings. The largest holders were CVI Holdings, LLC ($62K), Clear Street LLC ($150) and UBS Group AG ($149).
- Company
- Lexaria Bioscience -CW25
- CUSIP
- 52886N117
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $299 |
| Exits | 2 | $105K |
Ownership 3 holders
| CVI Holdings, LLC | — | No change | 41,651 | $62K |
| Clear Street LLC | — | New | 100 | $150 |
| UBS Group AG | — | New | 99 | $149 |
"% of holder's portfolio" is LEXXW's weight in each manager's 13F, not the share of Lexaria Bioscience -CW25 the manager owns.